Senior insider sale
Chief Business Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$714.6K
23.33K shares
What this filing means
MEYER ANDREW HOLLMAN plans to sell 23.33K shares of JANUX THERAPEUTICS, INC. valued at approximately $714.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/1/2025ACC: 0001950047-25-009526
Officer· Chief Business Officer
Since Jun 2021
23.33K
Shares to sell
$714.6K
Approx. market value
3.33K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/1/2025
3.33KTotal acquired3.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/1/2025 | Exercise of Stock Options Cash | 3.33K | — |
| Total | 3.33K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.33K
Market value
$100.0K
11/14/2025
—Completed
Units to sell
16.66K
Market value
$501.0K
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.33K
Market value
$113.6K
12/1/2025
Total
Units
23.33K
Value
$714.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/14/2025 | 3.33K | $100.0K | — | Completed |
10/28/2025 | 16.66K | $501.0K | — | Completed |
| Planned — Approximate Date | ||||
12/1/2025 | 3.33K | $113.6K | NASDAQ | Planned |
| Total | 23.33K | $714.6K | ||